The global intestinal failure oral nutrition market is projected to grow from USD 160.7 million in 2026 to USD 322.1 million by 2036, expanding at a 7.2% CAGR, according to Future Market Insights (FMI). The market was valued at USD 149.9 million in 2025, with demand supported by the need for carefully selected oral nutrition and hydration strategies among patients with intestinal failure.
Oral nutrition products can play a role for patients who are able to tolerate increasing levels of oral intake, including those transitioning away from greater dependence on parenteral nutrition (PN). Product selection remains highly individualized because intestinal absorption, fluid losses, hydration requirements, and gastrointestinal tolerance can differ substantially between patients.
👉 Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends:
https://www.futuremarketinsights.com/reports/sample/rep-gb-35279
Key Market Highlights at a Glance
- The market is valued at USD 160.7 million in 2026.
- Market valuation is forecast to reach USD 322.1 million by 2036.
- The market is projected to expand at a 7.2% CAGR from 2026 to 2036.
- Elemental / semi-elemental oral nutritional supplements (ONS) are projected to account for 42.4% of product type demand in 2026.
- Short bowel syndrome is expected to represent 50.3% of demand by etiology.
- PN-weaning leads the PN dependence category with a projected 48.0% share in 2026.
- South Korea records the highest listed country CAGR at 7.4%, followed by the USA at 6.9%.
- Key markets covered include the USA, UK, Germany, Japan, and South Korea.
Short Bowel Syndrome Drives Specialized Nutrition Requirements
Short bowel syndrome is projected to account for 50.3% of demand by etiology in 2026, highlighting the importance of specialized nutritional management where reduced intestinal length can affect nutrient and fluid absorption.
Patients with intestinal failure may require different combinations of oral nutrition, hydration support, and intravenous nutrition depending on their individual condition. As oral intake increases, clinicians can adjust nutritional strategies according to absorption and tolerance rather than relying on a single standardized formula.
This is supporting demand for specialized products designed for patients with complex digestive and nutritional requirements. Elemental and semi-elemental ONS products are projected to capture 42.4% of product type demand in 2026, reflecting their role within specialist nutrition strategies.
PN-Weaning Creates an Important Market Segment
The PN-weaning segment is projected to hold 48.0% of demand in the PN dependence category in 2026. The segment reflects the clinical pathway followed by some patients as their ability to tolerate and absorb oral nutrition improves.
However, reducing intravenous nutritional support depends on patient-specific clinical factors. Oral nutrition products alone do not determine whether a patient can discontinue PN. Specialist teams typically consider nutritional status, intestinal function, fluid balance, absorption, and tolerance when developing or modifying a nutrition plan.
This creates opportunities for manufacturers to develop products that provide practical nutritional support while fitting into specialist-led home nutrition programs.
Hydration and Tolerance Remain Central to Product Selection
Hydration is a particularly important consideration for patients with short bowel syndrome. Oral nutritional products and oral rehydration solutions address different requirements, making formulation and intended use important factors in product selection.
Healthcare professionals may assess fluid losses and absorption before recommending an appropriate hydration or nutrition strategy. This reinforces the importance of clear product information and specialist guidance as the market expands.
Access can also vary between healthcare systems. In the USA, reimbursement for oral nutrition products can present a practical challenge following hospital discharge. The UK follows specialist nutrition and hydration protocols, while treatment approaches in Germany emphasize individualized care. In Japan, product information and tolerability can influence use in short bowel states. South Korean clinical experience also highlights the continuing support required for patients receiving home parenteral nutrition.
👉 Access the Complete Report in PDF Format:
https://www.futuremarketinsights.com/reports/brochure/rep-gb-35279
Regional Growth Varies Across Key Markets
The market is expected to register different growth rates across major countries:
- South Korea: 7.4% CAGR, 2026–2036
- USA: 6.9% CAGR
- UK: 6.3% CAGR
- Germany: 5.9% CAGR
- Japan: 5.2% CAGR
These differences reflect variations in specialist care pathways, reimbursement environments, clinical practice, and access to home nutrition support.
Competitive Landscape
Key companies profiled in the intestinal failure oral nutrition market include Danone Nutricia (Elemental 028), Nestlé Health Science, Abbott, Ajinomoto Cambrooke, Kate Farms, Fresenius Kabi, and B. Braun.
Competition is shaped by specialized formulations, product tolerability, nutritional composition, distribution, and the ability to support patients across hospital-to-home care pathways.
Report Scope
Future Market Insights’ Intestinal Failure Oral Nutrition Market report provides analysis of market size, product types, etiologies, PN dependence categories, regional trends, and competitive developments. The report covers the 2026–2036 forecast period and includes the USA, UK, Germany, Japan, South Korea, and other markets.
The study comprises 250 pages and is authored by Anurag Sharma.
Access Full Report: https://www.futuremarketinsights.com/reports/intestinal-failure-oral-nutrition-market
Related Reports:
- https://www.openpr.com/news/4632094/small-modular-reactor-market-to-reach-usd-14-1-billion-by-2036-as
- https://www.openpr.com/news/4632102/sustainable-drug-manufacturing-market-to-reach-usd-248-2
- https://www.openpr.com/news/4632105/her2-therapy-market-growth-accelerates-as-demand-for-targeted
- https://www.openpr.com/news/4632106/single-use-downstream-biop rocessing-market-to-reach-usd-13-6
- https://www.openpr.com/news/4632114/skin-structure-infections-market-to-reach-usd-7-6-billion-by-2036
About Future Market Insights
Future Market Insights (FMI) is a global market intelligence and consulting firm providing syndicated research, custom research, and strategic advisory services across multiple industries. FMI’s research covers market sizing, forecasting, competitive intelligence, and industry analysis to support business planning and strategic decision-making.
For Press & Corporate Inquiries
Rahul Singh
AVP – Marketing and Growth Strategy
Future Market Insights, Inc.
+91 8600020075
Future Market Insights
Email: [email protected]
Website: https://www.futuremarketinsights.com/
